Albert ML - Search Results

1

Visualizing the functional diversification of CD8+ T cell responses in lymph nodes.

Beuneu H, Lemaître F, Deguine J, Moreau HD, Bouvier I, Garcia Z, Albert ML, Bousso P. Beuneu H, et al. Among authors: albert ml. Immunity. 2010 Sep 24;33(3):412-23. doi: 10.1016/j.immuni.2010.08.016. Immunity. 2010. PMID: 20850354 Free article.

2

Cutting edge: cross-presented intracranial antigen primes CD8+ T cells.

Walter L, Albert ML. Walter L, et al. Among authors: albert ml. J Immunol. 2007 May 15;178(10):6038-42. doi: 10.4049/jimmunol.178.10.6038. J Immunol. 2007. PMID: 17475827

3

Antigen persistence is required for dendritic cell licensing and CD8+ T cell cross-priming.

Jusforgues-Saklani H, Uhl M, Blachère N, Lemaître F, Lantz O, Bousso P, Braun D, Moon JJ, Albert ML. Jusforgues-Saklani H, et al. Among authors: albert ml. J Immunol. 2008 Sep 1;181(5):3067-76. doi: 10.4049/jimmunol.181.5.3067. J Immunol. 2008. PMID: 18713977

4

Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies.

Alanio C, Lemaitre F, Law HK, Hasan M, Albert ML. Alanio C, et al. Among authors: albert ml. Blood. 2010 May 6;115(18):3718-25. doi: 10.1182/blood-2009-10-251124. Epub 2010 Mar 3. Blood. 2010. PMID: 20200354 Free article.

5

Signal 0 for guided priming of CTLs: NKT cells do it too.

Bousso P, Albert ML. Bousso P, et al. Among authors: albert ml. Nat Immunol. 2010 Apr;11(4):284-6. doi: 10.1038/ni0410-284. Nat Immunol. 2010. PMID: 20300136 Review. No abstract available.

6

Visualizing the innate and adaptive immune responses underlying allograft rejection by two-photon microscopy.

Celli S, Albert ML, Bousso P. Celli S, et al. Among authors: albert ml. Nat Med. 2011 Jun;17(6):744-9. doi: 10.1038/nm.2376. Epub 2011 May 15. Nat Med. 2011. PMID: 21572426

7

Cutting Edge: A dual role for type I IFNs during polyinosinic-polycytidylic acid-induced NK cell activation.

Beuneu H, Deguine J, Bouvier I, Di Santo JP, Albert ML, Bousso P. Beuneu H, et al. Among authors: albert ml. J Immunol. 2011 Sep 1;187(5):2084-8. doi: 10.4049/jimmunol.1004210. Epub 2011 Aug 1. J Immunol. 2011. PMID: 21810605

8

Dying to replicate: the orchestration of the viral life cycle, cell death pathways, and immunity.

Yatim N, Albert ML. Yatim N, et al. Among authors: albert ml. Immunity. 2011 Oct 28;35(4):478-90. doi: 10.1016/j.immuni.2011.10.010. Immunity. 2011. PMID: 22035840 Free article.

9

Immunization route dictates cross-priming efficiency and impacts the optimal timing of adjuvant delivery.

Bouvier I, Jusforgues-Saklani H, Lim A, Lemaître F, Lemercier B, Auriau C, Nicola MA, Leroy S, Law HK, Bandeira A, Moon JJ, Bousso P, Albert ML. Bouvier I, et al. Among authors: albert ml. Front Immunol. 2011 Dec 8;2:71. doi: 10.3389/fimmu.2011.00071. eCollection 2011. Front Immunol. 2011. PMID: 22566860 Free PMC article.

10

Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.

Biot C, Rentsch CA, Gsponer JR, Birkhäuser FD, Jusforgues-Saklani H, Lemaître F, Auriau C, Bachmann A, Bousso P, Demangel C, Peduto L, Thalmann GN, Albert ML. Biot C, et al. Among authors: albert ml. Sci Transl Med. 2012 Jun 6;4(137):137ra72. doi: 10.1126/scitranslmed.3003586. Sci Transl Med. 2012. PMID: 22674550

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters